Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,914Revenue (TTM) $M1,492Net Margin (%)9.5Altman Z-Score2.2
Enterprise Value $M5,104EPS (TTM) $3.0Operating Margin %14.6Piotroski F-Score6
P/E(ttm)28.0Beneish M-Score-2.7Pre-tax Margin (%)14.0Higher ROA y-yY
Price/Book4.710-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow15.9y-y EBITDA Growth Rate %16.7ROA % (ttm)6.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)18.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M47.3ROIC % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with CRL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CRLDavid Dreman 2016-06-30 Sold Out -0.49%$75.94 - $87.45
($82.27)
$ 82.761%Sold Out0
CRLRobert Olstein 2016-06-30 Add0.35%$75.94 - $87.45
($82.27)
$ 82.761%Add 130.18%55,901
CRLJohn Rogers 2016-06-30 Reduce-0.18%$75.94 - $87.45
($82.27)
$ 82.761%Reduce -12.17%1,464,130
CRLJoel Greenblatt 2016-06-30 Reduce-0.05%$75.94 - $87.45
($82.27)
$ 82.761%Reduce -83.12%11,856
CRLKen Fisher 2016-06-30 Reduce$75.94 - $87.45
($82.27)
$ 82.761%Reduce -2.59%516,128
CRLDavid Dreman 2016-03-31 Buy 0.49%$67.1 - $80.39
($74.1)
$ 82.7612%New holding57,090
CRLRobert Olstein 2016-03-31 Buy 0.25%$67.1 - $80.39
($74.1)
$ 82.7612%New holding24,286
CRLJohn Rogers 2016-03-31 Reduce-0.07%$67.1 - $80.39
($74.1)
$ 82.7612%Reduce -4.36%1,666,955
CRLJoel Greenblatt 2016-03-31 Buy 0.06%$67.1 - $80.39
($74.1)
$ 82.7612%New holding70,227
CRLKen Fisher 2016-03-31 Add$67.1 - $80.39
($74.1)
$ 82.7612%Add 2.58%529,834
CRLDavid Dreman 2015-12-31 Sold Out -0.39%$61.75 - $80.54
($72.46)
$ 82.7614%Sold Out0
CRLJohn Rogers 2015-12-31 Add0.07%$61.75 - $80.54
($72.46)
$ 82.7614%Add 4.09%1,742,890
CRLJoel Greenblatt 2015-12-31 Sold Out -0.02%$61.75 - $80.54
($72.46)
$ 82.7614%Sold Out0
CRLKen Fisher 2015-12-31 Add0.01%$61.75 - $80.54
($72.27)
$ 82.7615%Add 6.96%516,495
CRLJoel Greenblatt 2015-09-30 Buy 0.02%$61.59 - $77.62
($71.85)
$ 82.7615%New holding29,055
CRLDavid Dreman 2015-09-30 Add0.02%$61.59 - $77.62
($71.85)
$ 82.7615%Add 4.96%61,274
CRLJohn Rogers 2015-09-30 Reduce$61.59 - $77.62
($71.85)
$ 82.7615%Reduce -0.32%1,674,330
CRLKen Fisher 2015-09-30 Reduce$61.59 - $77.62
($71.85)
$ 82.7615%Reduce -5.00%482,899
CRLJohn Rogers 2015-06-30 Reduce-0.07%$69.16 - $79.29
($74.08)
$ 82.7612%Reduce -4.48%1,679,650
CRLKen Fisher 2015-06-30 Add0.01%$69.16 - $79.29
($74.08)
$ 82.7612%Add 26.30%508,316
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CRL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CRL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Molho DavideCorporate Executive VP 2016-08-30Sell7,877$84.1-1.59view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell3,830$86.91-4.78view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell8,703$86.3-4.1view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell15,941$85.95-3.71view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell13,175$85.8-3.54view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell18,351$85.63-3.35view
WALLMAN RICHARD FDirector 2016-07-29Sell7,740$88-5.95view
MASSARO GEORGEDirector 2016-07-01Sell800$83.54-0.93view
MASSARO GEORGEDirector 2016-07-01Sell3,740$83.09-0.4view
Crowley John JSVP, Chief Accounting Officer 2016-05-24Sell1,913$85-2.64view

Press Releases about CRL :

Quarterly/Annual Reports about CRL:

News about CRL:

Articles On GuruFocus.com
Bob Olstein's Olstein Strategic Opportunities Fund 2nd Quarter Commentary Sep 01 2016 
Olstein Strategic Opportunities Fund 1st Quarter Letter to Shareholders Jun 07 2016 
Olstein All Cap Value Fund First Quarter Commentary Jun 01 2016 
Weekly Highlight of CEO Sells Oct 13 2014 
John Rogers Comments on Charles River Laboratories Intl Inc Jul 22 2014 
John Rogers' Ariel Fund Second Quarter 2014 Commentary Jul 22 2014 
Robert Olstein’s Largest New Stock Picks Feb 12 2013 
Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE Jan 13 2013 
Ariel Funds Top Buys: "We think like Halvorsen: CRL is a buy" Jan 11 2012 
Stocks I Can Buy Much Cheaper Than Halvorsen Did Jan 11 2012 

More From Other Websites
Charles River Laboratories and The Tri-Insitutional Therapeutics Discovery Institute Announce... Sep 22 2016
Charles River Laboratories and The Tri-Insitutional Therapeutics Discovery Institute Announce... Sep 22 2016
Jim Cramer's Top Takeaways: Impinj, Charles River Labs Sep 13 2016
Charles River downgraded by UBS Sep 06 2016
Charles River Laboratories to Present at September Investor Conferences Sep 06 2016
Charles River Laboratories to Present at September Investor Conferences Sep 06 2016
Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish... Aug 31 2016
Moody's Upgrades Two, Affirms Three and Downgrades One Class of MLCFC 2006-2 Aug 18 2016
Will This Clinical Researcher Become Next Breakout Medical Stock? Aug 11 2016
ETF’s with exposure to Charles River Laboratories International, Inc. : August 10, 2016 Aug 10 2016
CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials Aug 10 2016
Charles River Laboratories International, Inc. breached its 50 day moving average in a Bearish... Aug 09 2016
Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and... Aug 08 2016
Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and... Aug 08 2016
Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and... Aug 08 2016
Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: Q2, 2016 By the Numbers :... Aug 08 2016
Edited Transcript of CRL earnings conference call or presentation 3-Aug-16 12:30pm GMT Aug 03 2016
Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today Aug 03 2016
CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial... Aug 03 2016
Charles River beats Street 2Q forecasts Aug 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)